Quick Answer
AVANOS MEDICAL, INC. reported Diluted EPS of $1.57 per share (loss) for fiscal year 2025.
AVANOS MEDICAL, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.57 | +81.6% |
| 2024 | -$8.53 | -546.2% |
| 2023 | -$1.32 | -223.4% |
| 2022 | $1.07 | +723.1% |
| 2021 | $0.13 | +121.3% |
| 2020 | -$0.61 | +36.5% |
| 2019 | -$0.96 | -178.7% |
| 2018 | $1.22 | -27.8% |
| 2017 | $1.69 | +98.8% |
| 2016 | $0.85 | +109.3% |
| 2015 | -$9.15 | -1677.6% |
| 2014 | $0.58 | -82.5% |
| 2013 | $3.32 | +1.2% |
| 2012 | $3.28 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.03 | -133.3% | +98.2% |
| June 30, 2025 | -$1.66 | -4250.0% | -1285.7% |
| March 31, 2025 | $0.14 | +800.0% | +55.6% |
| September 30, 2024 | $0.09 | +212.5% | +125.0% |
| June 30, 2024 | $0.04 | +102.7% | +300.0% |
| March 31, 2024 | -$0.02 | -100.0% | +75.0% |
| September 30, 2023 | -$0.08 | -124.2% | +94.5% |
| June 30, 2023 | -$1.46 | -661.5% | -14500.0% |
- AVANOS MEDICAL, INC. showed an increase of +81.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2012–2025 period, AVANOS MEDICAL, INC.’s diluted eps has declined by 147.9% (from $3.28 per share to $1.57 per share (loss)).
- The most recent figure is from AVANOS MEDICAL, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: